Literature DB >> 28010924

Upregulation of NRF2 through autophagy/ERK 1/2 ameliorates ionizing radiation induced cell death of human osteosarcoma U-2 OS.

Ni Chen1, Rui Zhang2, Teruaki Konishi3, Jun Wang4.   

Abstract

The antioxidative response mediated by transcription factor NRF2 is thought to be a pivotal cellular defense system against various extrinsic stresses. It has been reported that activation of the NRF2 pathway confers cells with resistance to ionizing radiation-induced damage. However, the underlying mechanism remains largely unknown. In the current research, it was found that α-particle radiation has the ability to stimulate NRF2 expression in human osteosarcoma U-2 OS cells. Knockdown of cellular NRF2 level by shRNA-mediated gene silencing decreased the survival rate, increased the micronucleus formation rate and apoptosis rate in irradiated cells. Consistently, knockdown of NRF2 resulted in decreased expression of p65 and Bcl-2, and increased expression of p53 and Bax. Besides, it was observed that increased expression of NRF2 was partially dependent on radiation induced phosphorylation of ERK 1/2. Further results showed that radiation promoted autophagy flux which leads to the enhanced phosphorylation of ERK 1/2, as evidenced by the resultls that knockdown of ATG5 (Autophagy protein 5) gene by shRNA suppressed both radiation induced ERK 1/2 phosphorylation and NRF2 upregulation. Based on these results, it is proposed that attenuation of NRF2 antioxidative pathway can sensitize U-2 OS cells to radiation, where NRF2 antioxidative response is regulated by autophagy mediated activation of ERK 1/2 kinases.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; ERK1/2; Ionizing radiation; NRF2; Radio-sensitization

Mesh:

Substances:

Year:  2016        PMID: 28010924     DOI: 10.1016/j.mrgentox.2016.11.006

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

1.  Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway.

Authors:  Pan He; Zhijun Wang; Bin Sheng; Yongqiang Xu; Siyin Feng; Yan Huang; Fuqiang Gong; Liting Tang; Liming Xie
Journal:  Histol Histopathol       Date:  2020-12-29       Impact factor: 2.303

2.  Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455.

Authors:  Narisa Dewi Maulany Darwis; Eisuke Horigome; Shan Li; Akiko Adachi; Takahiro Oike; Atsushi Shibata; Yuka Hirota; Tatsuya Ohno
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

3.  Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.

Authors:  Peng-Cheng Li; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek; Zhijian Duan; Qian-Yu Zhang; Ai-Xi Yu; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2017-10-23       Impact factor: 3.922

4.  Treatment of Saos-2 osteosarcoma cells with diallyl trisulfide is associated with an increase in calreticulin expression.

Authors:  Wen-Peng Xie; Yue Zhang; Yong-Kui Zhang; Gang Li; Jian Xin; Rong-Xiu Bi; Chuan-Jie Li
Journal:  Exp Ther Med       Date:  2018-04-05       Impact factor: 2.447

Review 5.  p53 and metabolism: from mechanism to therapeutics.

Authors:  Fernando M Simabuco; Mirian G Morale; Isadora C B Pavan; Ana P Morelli; Fernando R Silva; Rodrigo E Tamura
Journal:  Oncotarget       Date:  2018-05-04

Review 6.  Dual effects of active ERK in cancer: A potential target for enhancing radiosensitivity.

Authors:  Yinliang Lu; Baocai Liu; Ying Liu; Xinyue Yu; Guanghui Cheng
Journal:  Oncol Lett       Date:  2020-05-28       Impact factor: 2.967

7.  Nuclear factor (erythroid-derived 2)-like 2 antioxidative response mitigates cytoplasmic radiation-induced DNA double-strand breaks.

Authors:  Jun Wang; Teruaki Konishi
Journal:  Cancer Sci       Date:  2019-02-01       Impact factor: 6.716

8.  PLK1 contributes to autophagy by regulating MYC stabilization in osteosarcoma cells.

Authors:  Hao Mo; Juliang He; Zhenchao Yuan; Zhenjie Wu; Bin Liu; Xiang Lin; Jian Guan
Journal:  Onco Targets Ther       Date:  2019-09-12       Impact factor: 4.147

9.  MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660.

Authors:  Hua-Jian Shan; Lun-Qing Zhu; Chen Yao; Zhi-Qing Zhang; Yuan-Yuan Liu; Qin Jiang; Xiao-Zhong Zhou; Xiao-Dong Wang; Cong Cao
Journal:  Mol Ther Nucleic Acids       Date:  2021-03-13       Impact factor: 8.886

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.